The emergence of bacteria that co-express serine- and metallo- carbapenemases is a threat to the efficacy of the available -lactam antibiotic armamentarium. The 4-amino-1,2,4-triazole-3-thione scaffold has been selected as the starting chemical moiety in the design of a small library of -Lactamase inhibitors (BLIs) with extended activity profiles. The synthesised compounds have been validated in vitro against class A serine Lactamase (SBLs) KPC-2 and class B1 metallo Lactamases (MBLs) VIM-1 and IMP-1. Of the synthesised derivatives, four compounds showed cross-class micromolar inhibition potency and therefore underwent analyses to elucidate their binding mode within the catalytic pockets of serine- and metallo-BLs. Moreover, several members of the synthesised library have been evaluated, in combination with meropenem (MEM), against clinical strains that overexpress BLs for their ability to synergise carbapenems.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151704 | PMC |
http://dx.doi.org/10.3390/ph13030052 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!